[Diabetes mellitus, hyperuricemia and pyelonephritis].
The following groups of patients are discussed. 1st group: 51 patients with diabetes mellitus and chronic pyelonephritis, 2nd group: 15 patients with diabetes, hyperuricaemia, adiposity and pyelonephritis. It was established that in the first group pyelonephritis was therapeutically well to be influenced by antiobiotics and chemotherapeutics after stopping of diabetes. In the second group the success was less satisfactory and it was also to be achieved retardedly on account of the massive renal lesion, by the combination of diabetes and uricopathy. The clinical syndrome of diabetes mellitus, hyperuricaemia and adiposity is discussed.
D000328:Adult; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D009765:Obesity / Q000150:complications* / Q000178:diet therapy; D011687:Purines / Q000378:metabolism; D011704:Pyelonephritis / Q000150:complications*; D014527:Uric Acid / Q000097:blood
D007004:Hypoglycemic Agents; D011687:Purines; D014527:Uric Acid
Diabetes mellitus, Hyperurikämie und Pyelonephritis